Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer

NCT01722162 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Bevacizumab
DRUG: Capecitabine
DRUG: Levocetirizine

Sponsor

Washington University School of Medicine